 |
The Chairman of the IMSB is Professor Alan Thompson, MD, FRCP, FRCPI, Director of the Institute of Neurology, University College London, and head of the Neurorehabilitation research area in the Institute’s Department of Brain Repair & Rehabilitation, Deputy Director of the UCL/UCLH Comprehensive Biomedical Research Centre, and a consultant neurologist at the National Hospital for Neurology & Neurosurgery.
He is the Editor-in-Chief of the journal Multiple Sclerosis. His research interests include the investigation of mechanisms that underlie disability in neurological conditions, particularly multiple sclerosis, the development of outcome measures which assess the impact of such conditions and the improvement of symptomatic management and service delivery in MS. He has published extensively in each of these areas.
Prof. Alan Thompson
His achievements in research include:
- Original MRI studies which demonstrated clear differences between primary progressive MS (PPMS) and other forms of the condition. More recently lead on establishing diagnostic criteria for diagnosing PPMS
- Use of functional MRI to explore potential for brain plasticity in optic neuritis and PPMS
- First randomised controlled trial of neurological rehabilitation in MS with Dr Jenny Freeman, which demonstrated clear benefits in patients with progressive MS
- Establishment of a Neurological Outcome Measures Unit at the Institute of Neurology with Dr Jeremy Hobart and developed two new outcome measures for MS – the MS Impact Scale and the MS Walking Scale
- Development of Standards of Care with the MS Society. Involved in NICE Guideline for MS and National Service Framework for long term conditions
|
|
